APA

Glatthar R., Stojanovic A., Troxler T., Mattes H., Möbitz H., Beerli R., Blanz J., Gassmann E., Drückes P., Fendrich G., Gutmann S., Martiny-Baron G., Spence F., Hornfeld J., Peel J. E. & Sparrer H. (20170606). Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors. : Journal of medicinal chemistry.

Chicago

Glatthar Ralf, Stojanovic Aleksandar, Troxler Thomas, Mattes Henri, Möbitz Henrik, Beerli Rene, Blanz Joachim, Gassmann Ernst, Drückes Peter, Fendrich Gabriele, Gutmann Sascha, Martiny-Baron Georg, Spence Fiona, Hornfeld Jeff, Peel John Edmonson and Sparrer Helmut. 20170606. Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors. : Journal of medicinal chemistry.

Harvard

Glatthar R., Stojanovic A., Troxler T., Mattes H., Möbitz H., Beerli R., Blanz J., Gassmann E., Drückes P., Fendrich G., Gutmann S., Martiny-Baron G., Spence F., Hornfeld J., Peel J. E. and Sparrer H. (20170606). Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors. : Journal of medicinal chemistry.

MLA

Glatthar Ralf, Stojanovic Aleksandar, Troxler Thomas, Mattes Henri, Möbitz Henrik, Beerli Rene, Blanz Joachim, Gassmann Ernst, Drückes Peter, Fendrich Gabriele, Gutmann Sascha, Martiny-Baron Georg, Spence Fiona, Hornfeld Jeff, Peel John Edmonson and Sparrer Helmut. Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors. : Journal of medicinal chemistry. 20170606.